TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	442.21	79.15	179.89	92.93	102.3	298.89
Short-Term Investments	72.22	62.82	131.11	124.58	59.37	15.88
Cash & Short-Term Investments	514.43	141.97	311	217.51	161.68	314.76
Cash Growth	86.23%	-54.35%	42.98%	34.53%	-48.63%	-48.01%
Accounts Receivable	392.05	305.63	129.19	51.09	-	1.39
Inventory	129.03	125.59	110.46	39.82	-	-
Other Current Assets	51.46	57.58	15.72	9.52	6.6	14.81
Total Current Assets	1,087	630.76	566.36	317.94	168.27	330.97
Net Property, Plant & Equipment	6.48	6.28	7.15	8.05	10.82	11.07
Goodwill	-	-	-	-	0.8	0.8
Long-Term Investments	61.54	59.14	0.81	-	12.4	35.53
Other Long-Term Assets	373.85	367.08	3.37	3.59	1.27	1.26
Total Assets	1,529	1,063	577.69	329.59	193.57	379.63
Accounts Payable	148.85	107.51	58.3	38.47	42.02	51.29
Accrued Expenses	18.66	21.85	15.19	12.17	8.43	10.17
Current Portion of Long-Term Debt	-	-	-	-	-	0.98
Current Portion of Leases	1.82	1.04	1.16	1.45	1.58	1.44
Unearned Revenue	17.19	21.23	11.41	0.15	-	-
Other Current Liabilities	0.6	2.12	4.63	1.48	1.17	1.51
Total Current Liabilities	187.11	153.76	90.68	53.72	53.2	65.38
Long-Term Debt	745.14	245.65	244.43	100.12	71.14	66.79
Long-Term Leases	6.6	7.02	8.13	9.23	10.34	9.85
Other Long-Term Liabilities	6.86	8.81	12.09	6.02	0.31	0.46
Total Long-Term Liabilities	758.6	261.47	264.65	115.37	81.78	77.09
Total Liabilities	945.71	415.23	355.33	169.09	134.99	142.48
Common Stock	0.16	0.16	0.16	0.15	0.15	0.14
Treasury Stock	-200.23	-100.23	-8.99	-0.23	-0.23	-0.23
Additional Paid-in Capital	1,845	1,830	1,760	1,713	1,586	1,566
Retained Earnings	-1,062	-1,082	-1,529	-1,553	-1,527	-1,329
Shareholders' Equity	583.13	648.02	222.36	160.5	58.59	237.15
Total Liabilities & Equity	1,529	1,063	577.69	329.59	193.57	379.63
Total Debt	753.56	253.71	253.72	110.8	83.06	79.05
Net Cash (Debt)	-239.13	-111.74	57.28	106.71	78.62	235.72
Net Cash Growth	-	-	-46.32%	35.74%	-66.65%	-58.17%
Net Cash Per Share	-1.49	-0.69	0.36	0.72	0.58	1.78
Book Value	583.13	648.02	222.36	160.5	58.59	237.15
Book Value Per Share	3.63	4.01	1.39	1.08	0.43	1.79
Tangible Book Value	583.13	648.02	222.36	160.5	57.79	236.35
Tangible Book Value Per Share	3.63	4.01	1.39	1.08	0.43	1.79

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q